NCT05433987Completed
Immune Activation Markers in HIV-infected Patients Switching to Long Acting Dual Therapy
Study Aiming to Measure the Impact on Immune Activation and Inflammatory Markers of Switching From a Triple Combination Antiretroviral Therapy (cART) to a Long Acting Dual Therapy in HIV-infected Patients
Source: ClinicalTrials.gov · Last updated 28 Aug 2024
Brief summary (registry, in English)
The purpose of the study is to measure the impact on immune activation and inflammatory markers of switching from a triple combination antiretroviral therapy (cART) to a long acting dual therapy in HIV-infected patients
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 20 (actual)
- First submitted
- 21 Jun 2022
- Start date
- 28 Jul 2022
- Primary completion date
- 17 Nov 2023
- Lead sponsor
- Centre Hospitalier de Cannes Simone Veil
- Diseases
- HIV
- NCT number
- NCT05433987
What you commit to
- Study type: Observational
- Participants enrolled: 20
- From 28 Jul 2022 to the primary completion date, 17 Nov 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- HIV-2 infected subjects
- Patients having being treated during acute HIV-infection
- Patients modifying cART for virological failure
Other
- Patients not being on successful and stable cART
- Subjects modifying their treatment for another combination than from a triple cART to a dual cART
- Patients modifying cART during the 6 months of follow-up
- Patients refusing to participate to the study
- Patients included in an interventional study during the 6 months of follwo-up
- Patient under juridical procedure
Who the study is looking for
- Patients agreeing to participate to the study and to collect their data
- HIV-1 infected subjects
- Patients switching from a stable (at least 6 months) and successful triple cART to a long acting dual cART
- Patients older than 18 yrs and regularly followed in Cannes and Nice hospitals
- Patients with a healthcare card
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Nathalie DOUX Coordinator of this site? Confirm its status | Cannes | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.